Among users of antidementia drugs, persons using memantine have the highest risk of pneumonia, new research shows. The use of rivastigmine patches is associated with an increased risk as wel...
Imagine swallowing a pill today that continues releasing the daily dose of a medicine you need for the next week, month or even longer. Investigators from Brigham and Women's Hospital and th...
Among a group of older women, self-reported caffeine consumption of more than 261 mg per day was associated with a 36 percent reduction in the risk of incident dementia over 10 years of foll...
New research was presented at AAIC 2016, the annual Alzheimer’s Association International Conference, from July 22 to 28 in Toronto. The features below highlight some of the studies emergi...
Could it be that Alzheimer’s disease stems from the toxic remnants of the brain’s attempt to fight off infection? New research by a team of investigators at Harvard leads to this startli...
The following depicts the population aged 65 and older by number of disabilities and age, based on data from 2008 to 2012. ...
Adults who were moderately deficient or severely deficient in vitamin D had a 53% and 125% increased risk of developing dementia, respectively, in the largest study examining the link betwee...
A new drug may improve memory problems in people with moderate Alzheimer’s disease, according to a phase IIa study released today that will be presented at the American Academy of Neurolog...
Recent studies show that patients with Alzheimer’s Disease (AD) who are hospitalized are at increased risk for further cognitive decline, institutionalization, and death in the year follow...
National estimates demonstrate that elderly patients are increasingly presenting for care at EDs throughout the United States each year, and by current projections, this trend is expected to...
Visinin-like protein-1 (VILIP-1) and VILIP-1/ Aβ42—potential cerebrospinal fluid (CSF) markers of neuronal injury—appear to predict the rate of global cognitive decline similarly to tau...
Research has shown that many clinicians lack formal training in evaluating medical decision-making capacity. Typically, patients who may lack capacity are evaluated only when decisions to be...
The American Academy of Neurology has issued a position statement calling for clinicians to screen patients for abusive or violent treatment by family members, caregivers, and/or others. Ava...
The Alzheimer’s Association estimates that about 5.3 million Americans have Alzheimer’s disease. Within this group, roughly eight of 10 people have dementia but live outside of nursing h...
Light to moderate drinking—be it of beer, wine, or spirits—seems to reduce the risk for dementia and cognitive decline, according to a study recently released in Neuropsychiatric Disease...
Highlights from the AAN 2011 Annual Meeting include the relationship between cardiovascular risk factors and cognitive decline, using a cerebrospinal fluid test to determine MS onset of disa...
For the first time in nearly 30 years, the diagnostic criteria for Alzheimer’s disease (AD) have been updated in the April 19 online issue of Alzheimer’s & Dementia: The Journal of t...
Diabetes Type 3—a “brain specific” disease—is far from understood and very much uncharted territory in the medical community. Diagnosis and treatment strategies remain in the early s...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
